Vosevi (Sofosbuvir / Velpatasvir / Voxilaprevir)

Manufacturer:
Gilead
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
    Enrollment Forms:
    Synergen Prescription Form
    Patient Support Form

    Approved Indication:

    treatment of adult patients with chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis who have

    • genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an HCV regimen containing an NS5A inhibitor
    • genotype 1a or 3 infection and have previously been treated with an HCV regimen containing sofosbuvir without an NS5A inhibitor

    Conditions:

    • Chronic Viral Hepatitis C

    Therapeutic Area:

    • Gastroenterology
    • Infectious Disease
    • Hepatology